https://sodiumchannel-receptor.....com/index.php/low-d
MIBG). The novel PET-radiotracer F-18-flubrobenguane could change the diagnostic paradigm in suspected pheochromocytomas and paragangliomas because of its homology to MIBG together with basic advantages of PET-imaging. Purpose of this retrospective analysis would be to examine F-18-flubrobenguane in pheochromocytomas and paragangliomas and also to investigate the biodistribution in clients. Practices 24 customers with suspected pheochromocytoma and paraganglioma underwent PET/CT or PE
Like
Comment
Share
